Advanced small cell carcinoma of the uterine cervix treated by neoadjuvant chemotherapy with irinotecan and cisplatin followed by radical surgery

Rare Tumors

Volumn 3, Issue 1, 2011, Pages 18-20

  Nasu, Kaei ^a   Hirakawa, Tomoko ^a   Okamoto, Mamiko ^a   Nishida, Masakazu ^a   Kiyoshima, Chihiro ^a   Matsumoto, Harunobu ^a   Takai, Noriyuki ^a   Narahara, Hisashi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Multimodal therapy; Neoadjuvant chemotherapy; Small cell carcinoma; Uterine cervical cancer

Indexed keywords

AMRUBICIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IRINOTECAN;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MULTIPLE CYCLE TREATMENT; PARAAORTIC LYMPHADENECTOMY; PELVIS LYMPHADENECTOMY; POSTOPERATIVE PERIOD; PUNCH BIOPSY; SMALL CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERUS BIOPSY;

EID: 79952393635     PISSN: 20363605     EISSN: 20363613     Source Type: Journal    
DOI: 10.4081/rt.2011.e6     Document Type: Article

References (18)

1. Sheets EE, Berman ML, Hrountas CK, et al. Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol 1988; 71:10-4.
2. Hoskins PJ, Wong F, Swenerton K, et al. Small cell carcinoma of the cervix treated with concurrent radiotherapy, cisplatin, and etoposide. Gynecol Oncol 1995; 56:218-25.
3. Chang TC, Lai CH, Tseng CJ, et al. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer 1998; 83: 712-8.
4. Delaloge S, Pautier P, Kerbrat P, et al. Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature. Clin Oncol 2000; 12:357-62.
5. Straughn JM Jr, Richter HE, Conner MG, et al. Predictors of outcome in small cell carcinoma of the cervix-a case series. Gynecol Oncol 2001; 83:216-20.
6. Chan JK, Loizzi V, Burger RA, et al. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 2003; 97:568-74.
7. Hoskins PJ, Swenerton KD, Pike JA, et al. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol 2003; 21:3495-501.
8. Viswanathan AN, Deavers MT, Jhingran A, et al. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 2004; 93:27-33.
9. Petru E, Pasterk C, Reich O, et al. Small-cell carcinoma of the uterus and the vagina: experience with ten patients. Arch Gynecol Obstet 2005; 271:316-9.
10. Tsunoda S, Jobo T, Arai M, et al. Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases. Int J Gynecol Cancer 2005; 15:295-300.
11. Chen J, Macdonald K, Gaffney DK. Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix. Obstet Gynecol 2008; 111:1394-402.
12. Cohen JG, Kapp DS, Shin JY, et al. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol 2010; 203:347.e1-e6.
13. Lewandowski GS, Copeland LJ. A potential role for intensive chemotherapy in the treatment of small cell neuroendocrine tumors of the cervix. Gynecol Oncol 1993; 48:127-31.
14. Bermudez A, Vighi S, Garcia A, Sardi J. Neuroendocrine cervical carcinoma: a diagnostic and therapeutic challenge. Gynecol Oncol 2001; 82:32-9.
15. Lim FK, Chong SM, Sethi V. Small cell neuroendocrine carcinoma of the cervix with involvement of multiple pelvic nodes - A successfully treated case by multimodal approach. Gynecol Oncol 1999; 72:246-9.
16. Noda K, Nishiwaki Y, Kawahara M, et al.; Japan Clinical Oncology Group. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002; 346:85-91.
17. Ohe Y, Negoro S, Matsui K, et al. Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer. Ann Oncol 2005; 16:430-6.
18. Shimokawa T, Shibuya M, Kitamura K, et al. Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancer. Int J Clin Oncol 2009; 14:63-9.